Maple has acquired Beyond ADHD for an undisclosed amount. This transaction represents a corporate acquisition, where Maple has bought the innovative ADHD care provider. Beyond ADHD specializes in making ADHD diagnosis and treatment accessible, affordable, and effective for both children and adults across Canada. The company offers online ADHD assessments conducted by licensed nurse practitioners, personalized multimodal treatment plans that include medication and academic/workplace accommodations, and evidence-based strategies. Beyond ADHD has successfully supported over 13,000 individuals on their ADHD journey and assists patients with Disability Tax Credit applications and Student Disability Verification forms. Its services are reimbursed by most Medavie Blue Cross plans.
For Maple, a company operating in the digital health landscape, this acquisition is a strategic move to expand its specialized virtual care offerings. Beyond ADHD's established platform, pan-Canadian reach, and expertise in neurodevelopmental care address a significant need for accessible mental health services. The integration of Beyond ADHD's comprehensive suite of services, from initial assessment to ongoing treatment and support, enhances Maple's portfolio and reinforces its commitment to providing diverse healthcare solutions through technology. The acquisition leverages Beyond ADHD’s proven model and patient base, which has shown strong engagement and positive outcomes.
Expected synergies include an immediate expansion of Maple's specialized service capacity in ADHD care. By combining Beyond ADHD’s deep focus and patient-centric approach with Maple’s broader digital health infrastructure, the combined entity aims to streamline access to critical services. This integration is anticipated to improve efficiency in delivering specialized care, ultimately benefiting more individuals seeking support for ADHD. The collaboration is set to further advance accessible and affordable online ADHD care across the country, building on Beyond ADHD's mission.
The combined operations are poised to offer a more robust and integrated approach to virtual healthcare, particularly in the neurodevelopmental space. This strategic alignment is expected to scale the reach of high-quality ADHD diagnosis and treatment, supporting a growing population in need of timely and convenient care.